93 related articles for article (PubMed ID: 35483750)
1. Postdischarge outcomes of COVID-19 patients from South Asia: a prospective study.
Abeysuriya V; Seneviratne SL; De Silva AP; Mowjood R; Mowjood S; de Silva T; de Mel P; de Mel C; Wijesinha RS; Fernando A; de Mel S; Chandrasena L
Trans R Soc Trop Med Hyg; 2022 Dec; 116(12):1129-1137. PubMed ID: 35483750
[TBL] [Abstract][Full Text] [Related]
2. Neurological disorders associated with COVID-19 in Sri Lanka.
Chang T; Wijeyekoon R; Keshavaraj A; Ranawaka U; Senanayake S; Ratnayake P; Senanayake B; Caldera MC; Pathirana G; Sirisena D; Wanigasinghe J; Gunatilake S;
BMC Neurol; 2023 Oct; 23(1):351. PubMed ID: 37794324
[TBL] [Abstract][Full Text] [Related]
3. A prospective cohort study on post COVID syndrome from a tertiary care centre in Sri Lanka.
Jayasekera MMPT; De Silva NL; Edirisinghe EMDT; Samarawickrama T; Sirimanna SWDRC; Govindapala BGDS; Senanayake G; Wickramaratne DLN; Hettigoda K; Gunawaradana UDIB; Wijayananda KDPB; Wijesinghe RANK
Sci Rep; 2023 Sep; 13(1):15569. PubMed ID: 37730947
[TBL] [Abstract][Full Text] [Related]
4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study.
Verveen A; Wynberg E; van Willigen HDG; Davidovich U; Lok A; Moll van Charante EP; de Jong MD; de Bree G; Prins M; Knoop H; Nieuwkerk PT;
BMC Med; 2022 Nov; 20(1):422. PubMed ID: 36324167
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Profiles and Clinical Features of Coronavirus 2019 Survivors 3 Months After Discharge in Wuhan, China.
Zhou M; Yin Z; Xu J; Wang S; Liao T; Wang K; Li Y; Yang F; Wang Z; Yang G; Zhang J; Jin Y
J Infect Dis; 2021 Nov; 224(9):1473-1488. PubMed ID: 33822106
[TBL] [Abstract][Full Text] [Related]
7. Race, Ethnicity, and 60-Day Outcomes After Hospitalization With COVID-19.
Robinson-Lane SG; Sutton NR; Chubb H; Yeow RY; Mazzara N; DeMarco K; Kim T; Chopra V
J Am Med Dir Assoc; 2021 Nov; 22(11):2245-2250. PubMed ID: 34716006
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
[TBL] [Abstract][Full Text] [Related]
9. Early Mental Health and Quality of Life in Discharged Patients With COVID-19.
Hu J; Zhang Y; Xue Q; Song Y; Li F; Lei R; Wu J; Qian J
Front Public Health; 2021; 9():725505. PubMed ID: 35004560
[No Abstract] [Full Text] [Related]
10. Reduced dengue incidence during the COVID-19 movement restrictions in Sri Lanka from March 2020 to April 2021.
Surendran SN; Nagulan R; Sivabalakrishnan K; Arthiyan S; Tharsan A; Jayadas TTP; Raveendran S; Kumanan T; Ramasamy R
BMC Public Health; 2022 Feb; 22(1):388. PubMed ID: 35209890
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
14. Six-Month Outcomes in Patients Hospitalized with Severe COVID-19.
Horwitz LI; Garry K; Prete AM; Sharma S; Mendoza F; Kahan T; Karpel H; Duan E; Hochman KA; Weerahandi H
J Gen Intern Med; 2021 Dec; 36(12):3772-3777. PubMed ID: 34355349
[TBL] [Abstract][Full Text] [Related]
15. Physical, psychological, and social aspects of quality of life in filarial lymphedema patients in Colombo, Sri Lanka.
Wijesinghe RS; Wickremasinghe AR
Asia Pac J Public Health; 2015 Mar; 27(2):NP2690-701. PubMed ID: 22308536
[TBL] [Abstract][Full Text] [Related]
16. 'Why are you not dead yet?' - dimensions and the main driving forces of stigma and discrimination among COVID-19 patients in Sri Lanka.
Jayakody S; Hewage SA; Wickramasinghe ND; Piyumanthi RAP; Wijewickrama A; Gunewardena NS; Prathapan S; Arambepola C
Public Health; 2021 Oct; 199():10-16. PubMed ID: 34517288
[TBL] [Abstract][Full Text] [Related]
17. Evolutionary and genomic analysis of four SARS-CoV-2 isolates circulating in March 2020 in Sri Lanka; Additional evidence on multiple introduction and further transmission.
Satharasinghe DA; Parakatawella PMSDK; Premarathne JMKJK; Jayasooriya LJPAP; Prathapasinghe GA; Yeap SK
Epidemiol Infect; 2021 Mar; 149():e78. PubMed ID: 33722321
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life after 12 months post discharge in patients hospitalised with COVID-19-related severe acute respiratory infection (SARI): a prospective analysis of SF-36 data and correlation with retrospective admission data on age, disease severity, and frailty.
Wright G; Senthil K; Zadeh-Kochek A; Au JH; Zhang J; Huang J; Saripalli R; Khan M; Ghauri O; Kim S; Mohammed Z; Alves C; Koduri G
BMJ Open; 2024 Mar; 14(3):e076797. PubMed ID: 38508629
[TBL] [Abstract][Full Text] [Related]
19. Spatial distribution of COVID-19 patients in Sri Lanka.
Galgamuwa LS; Liyanawahunge NM; Ratnayake CG; Hakmanage NM; Aslam F; Dharmaratne SD
BMC Public Health; 2023 Sep; 23(1):1755. PubMed ID: 37689685
[TBL] [Abstract][Full Text] [Related]
20. Quality of life and persistence of COVID-19 symptoms 90 days after hospital discharge.
Muñoz-Corona C; Gutiérrez-Canales LG; Ortiz-Ledesma C; Martínez-Navarro LJ; Macías AE; Scavo-Montes DA; Guaní-Guerra E
J Int Med Res; 2022 Jul; 50(7):3000605221110492. PubMed ID: 35822272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
